Deerfield Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-52,555
Closed -$2.13M 103
2025
Q4
$2.13M Sell
52,555
-707,641
-93% -$30.8M 0.03% 94
2025
Q3
$35.8M Buy
760,196
+59,925
+9% +$3.11M 0.55% 42
2025
Q2
$36.5M Buy
700,271
+89,271
+15% +$4.9M 0.66% 34
2025
Q1
$36.9M Sell
611,000
-964
-0.2% -$62.1K 0.73% 32
2024
Q4
$41.9M Sell
611,964
-2,926
-0.5% -$204K 0.79% 31
2024
Q3
$44.2M Sell
614,890
-16,374
-3% -$1.16M 0.66% 33
2024
Q2
$43.8M Buy
631,264
+293,099
+87% +$21.4M 0.73% 34
2024
Q1
$27.1M Buy
338,165
+335,609
+13,130% +$29.9M 0.47% 42
2023
Q4
$280K Buy
+2,556
New +$264K 0.01% 130

Other funds holding CNMD

Deerfield Management's CNMD Position: Q1 2026 in Review

Deerfield Management sold out of CONMED (CNMD) in Q1 2026, closing a stake of 52,555 shares — an estimated $2.13M sold.

Deerfield Management first reported a position in CNMD in Q4 2023 and held it in 9 quarters. The position peaked at $44.2M in Q3 2024. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Deerfield Management reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
  • Deerfield Management sold 52,555 CONMED shares in Q1 2026, an estimated $2.13M.
  • Deerfield Management first reported a position in CONMED in Q4 2023 and held it in 9 quarters.
  • Deerfield Management's CONMED position peaked at $44.2M in Q3 2024.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Deerfield Management's 13F filing for Q1 2026, filed 15 May 2026.